Serum Institute of India Pvt. Ltd. logo

Serum Institute of India Pvt. Ltd.

Asia, Maharashtra, India, Pune

Description

Serum Institute is vaccine manufacturer by number of doses produced.

Investor Profile

Serum Institute of India Pvt. Ltd. has made 4 investments, with 1 in the past 12 months and 50% as lead.

Stage Focus

  • Series A (50%)
  • Series C (25%)
  • Series B (25%)

Country Focus

  • United States (75%)
  • Denmark (25%)

Industry Focus

  • Biotechnology
  • Medical
  • Genetics
  • Health Care
  • Clinical Trials
  • Health Diagnostics
  • Therapeutics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Serum Institute of India Pvt. Ltd. frequently co-invest with?

Bill & Melinda Gates Foundation
North America, New York, United States, New York
Co-Investments: 1
Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
Scientia Ventures
North America, New York, United States, New York
Co-Investments: 1
Allegheny Financial Group
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 1
Helicase Venture
North America, Massachusetts, United States, Boston
Co-Investments: 1
Connectivity Ventures Fund
North America, New York, United States, New York
Co-Investments: 1
CTI Life Sciences Fund
North America, Quebec, Canada, Montréal
Co-Investments: 1
Adjuvant Capital
North America, New York, United States, New York
Co-Investments: 2
Founders Fund
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by Serum Institute of India Pvt. Ltd.?

Hervolution Therapeutics

Copenhagen, Hovedstaden, Denmark

Hervolution Therapeutics develops immunotherapies targeting tumors using Human Endogenous Retroviral proteins (HERVs).

BiopharmaBiotechnologyGenetics
Series ADec 19, 2024
Amount Raised: $11,700,000
Codagenix

Farmingdale, New York, United States

Codagenix develops live-attenuated viral vaccines to provide target antigens placed in an attenuated backbone virus.

BiotechnologyGeneticsMedical
Series BFeb 15, 2023
Amount Raised: $25,000,000
X-Vax Technology

Jupiter, Florida, United States

X-VAX is a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes.

BiotechnologyHealth CareMedical
Series AJul 23, 2019
Amount Raised: $56,000,000
Visterra

Cambridge, Massachusetts, United States

Visterra researches on and develops therapeutic and diagnostic products for the treatment of infectious diseases.

BiotechnologyClinical TrialsHealth DiagnosticsTherapeutics
Series COct 5, 2017
Amount Raised: $23,600,000